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Summary 
Kindt et al.
1 published a report entitled “Intestinal immune 
activation in presumed post-infectious functional syspepsia” in 
the August issue of Neurogastroenterology and Motility in 2009. 
By comparing the signs of inflammation and the degree of hyper-
plasia of the enterochromaffin cells (EC) in duodenal biopsies 
obtained from patients with presumed post-infectious functional 
dyspepsia (PI-FD) and unspecified-onset functional dyspepsia 
(U-FD), they showed that PI-FD is associated with persistence 
of focal T-cell aggregates, decrease in CD4
+ cells and increased 
macrophage counts surrounding the crypts, without any sig-
nificant differences in the numbers of EC or chromogranin A 
(CA)-positive cells (mast cells). This finding may indicate im-
paired ability of the immune system in these cases to terminate the 
inflammatory response after an acute insult. 
Comment
In irritable bowel syndrome (IBS), a post-infectious disease 
entity was reported in 1962 by Chaudhary and Truelove, who 
showed that 23% of IBS patients gave a history of an episode of 
bacillary or amoebic dysentery.
2 Ever since, an increasing num-
ber of studies have reported on the development of post-in-
fectious IBS.
In relation to PI-FD, Mearin et al.
3 reported a significantly 
increased prevalence of FD up to 1 year after an outbreak of 
Salmonella gastroenteritis. In PI-FD patients, early satiety, 
weight loss, nausea, and vomiting are more frequently reported, 
while gastric sensorimotor function testing revealed a particularly 
high prevalence of impaired gastric accommodation.
4 In the 
study by Kindt et al.,
1 the focal aggregates of CD8
+ T cells, de-
crease in CD4
+ T cells and increased macrophage counts sur-
rounding the duodenal crypts persisted for several months after 
the acute infectious episodes, suggesting delay or impairment of 
termination of the inflammatory response even after adequate re-Hidekazu Suzuki
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moval of the infecting pathogen. 
Why did Kindt et al. choose duodenal mucosa over gastric bi-
opsies for the histopathological evaluation in the FD patients? As 
is well known, FD symptoms are mainly attributable to disturbed 
gastric function. However, the approach of studying in-
flammation in the duodenum has been used previously
5 and in 
fact, was reported to be more successful for detecting the changes 
in FD as compared to gastric biopsies.
6 According to the report 
by Lee et al.,
7 since duodenal acidification induces proximal gas-
tric relaxation, increases the sensitivity to gastric distension, and 
inhibits gastric accommodation to a meal, duodenal mucosa is al-
so an important sensory portion for the pathogenesis of FD. 
Furthermore, when histological inflammation is assessed by gas-
tric biopsy, we have to bear in mind the possible co-existence of 
Helicobacter pylori (H. pylori)  infection of the stomach. Even 
though the Rome III classification does not require ruling out of 
H. pylori infection for diagnosing FD,
8,9 the H. pylori-colonized 
gastric mucosa exhibits significant levels of inflammatory cell in-
filtration with CD8
+-, CD4
+-T cells and macrophages.
10-13 
Even after the eradication of H. pylori, many mononuclear cells as 
T cells or macrophages persist in the mucosa. Such inflammatory 
changes present before and even after H. pylori eradication could 
play a significant role in the pathophysiology of this type of 
dyspepsia. Taken together, functional dyspepsia with a present or 
even past history of H. pylori infection should be considered as a 
different disease entity from FD, such as H. pylori-infectious FD 
or post-H. pylori-infectious FD.
In conclusion, the concept of PI-FD is potentially valid and 
the causal relationship between remnant inflammatory features 
and the gastroduodenal motor or sensory machinery should be 
further investigated. However, the major microorganism infect-
ing the stomach, H. pylori, should not be overlooked when con-
sidering the pathophysiology of FD, especially in Asia. 
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